Bartlett G L, Kreider J W, Purnell D M
J Natl Cancer Inst. 1976 Dec;57(6):1297-303. doi: 10.1093/jnci/57.6.1297.
Intradermal (id) injection of three tumor-immune stimulant mixtures (LSTRA-BCG, 13762A-BCG, CaD2-Corynebacterium parvum) was superior to the sc site for suppression of tumor growth: Suppression of LSTRA-BCG mixtures was even less efficient after an ip or iv injectiouppression at all four sites. In the LSTRA-BCG model, the id site was not uniquely favorable for either the afferent or efferent limb of the immune response; the other sites produced equally effectiveimmunization or rejection of tumor challenge. We concluded that local suppression of tumor cell-immune stimulant mixtures was frequently more effective in the skin than at other sites, that local tumor suppression did not depend primarily on tumor immunity, and that afferent and efferent tumor immunity were equally efficient by the four routes tested.
皮内(id)注射三种肿瘤免疫刺激混合物(LSTRA - 卡介苗、13762A - 卡介苗、CaD2 - 短小棒状杆菌)在抑制肿瘤生长方面优于皮下(sc)注射部位:在腹腔内(ip)或静脉内(iv)注射后,LSTRA - 卡介苗混合物的抑制效果在所有四个部位都更差。在LSTRA - 卡介苗模型中,皮内注射部位对于免疫反应的传入或传出环节并非具有独特的优势;其他部位在肿瘤激发的免疫接种或排斥方面同样有效。我们得出结论,肿瘤细胞 - 免疫刺激混合物的局部抑制在皮肤中通常比在其他部位更有效,局部肿瘤抑制并不主要依赖于肿瘤免疫,并且在所测试的四种途径中,传入和传出肿瘤免疫同样有效。